Glial cell response: A pathogenic factor in Parkinson's disease

被引:26
|
作者
Wu, DC
Tieu, K
Cohen, O
Choi, DK
Vila, M
Jackson-Lewis, V
Teismann, P
Przedborski, S
机构
[1] Columbia Univ, Dept Neurol, Movement Disorder Div, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY USA
关键词
astrocyte; gliosis; IL-1; beta; iNOS; microglia; MPTP; neurodegeneration; Parkinson's disease;
D O I
10.1080/13550280290100905
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The loss of these neurons is associated with a glial response composed mainly of activated microglial cells and, to a lesser extent, of reactive astrocytes. This glial response may be the source of trophic factors and can protect against reactive oxygen species and glutamate. Alternatively, this glial response can also mediate a variety of deleterious events related to the production of pro-oxidant reactive species, proinflammatory prostaglandin, and cytokines. In this review, the authors discuss the potential protective and deleterious effects of glial cells in the SNpc of PD and examine how these factors; may contribute to the pathogenesis of this disease.
引用
收藏
页码:551 / 558
页数:8
相关论文
共 50 条
  • [1] Glial cell response: A pathogenic factor in Parkinson’s disease
    Du Chu Wu
    Kim Tieu
    Oren Cohen
    Dong-Kug Choi
    Miquel Vila
    Vernice Jackson-Lewis
    Peter Teismann
    Serge Przedborski
    Journal of NeuroVirology, 2002, 8 : 551 - 558
  • [2] Pathogenic role of glial cells in Parkinson's disease
    Teismann, P
    Tieu, K
    Cohen, O
    Choi, DK
    Wu, DC
    Marks, D
    Vila, M
    Jackson-Lewis, V
    Przedborski, S
    MOVEMENT DISORDERS, 2003, 18 (02) : 121 - 129
  • [3] Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease
    Yasuhara, Takao
    Shingo, Tetsuro
    Date, Isao
    ACTA MEDICA OKAYAMA, 2007, 61 (02) : 51 - 56
  • [4] Unraveling the role of glial cell line–derived neurotrophic factor in the treatment of Parkinson’s disease
    Violina Kakoty
    K. C. Sarathlal
    Palwinder Kaur
    Pankaj Wadhwa
    Sukriti Vishwas
    Farhan R. Khan
    Abdulfattah Yahya M. Alhazmi
    Hassan Hussain Almasoudi
    Gaurav Gupta
    Dinesh Kumar Chellappan
    Keshav Raj Paudel
    Dileep Kumar
    Kamal Dua
    Sachin Kumar Singh
    Neurological Sciences, 2024, 45 : 1409 - 1418
  • [5] Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease
    Whone, Alan L.
    Boca, Mihaela
    Luz, Matthias
    Woolley, Max
    Mooney, Lucy
    Dharia, Sonali
    Broadfoot, Jack
    Cronin, David
    Schroers, Christian
    Barua, Neil U.
    Longpre, Lara
    Barclay, C. Lynn
    Boiko, Chris
    Johnson, Greg A.
    Fibiger, H. Christian
    Harrison, Rob
    Lewis, Owen
    Pritchard, Gemma
    Howell, Mike
    Irving, Charlie
    Johnson, David
    Kinch, Suk
    Marshall, Christopher
    Lawrence, Andrew D.
    Blinder, Stephan
    Sossi, Vesna
    Stoessl, A. Jon
    Skinner, Paul
    Mohr, Erich
    Gill, Steven S.
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (02) : 301 - 313
  • [6] Glial neurotrophic factor as an early diagnostic marker in Parkinson's disease
    Matmurodov, M.
    Abduqodirov, A.
    Khalimova, L.
    Muminov, B.
    MOVEMENT DISORDERS, 2022, 37 : S591 - S592
  • [7] Targeting the Receptor of Glial Cell Line-Derived Neurotrophic factor to treat Parkinson's Disease
    Sidorova, Y.
    Mahato, A.
    Saarma, M.
    MOVEMENT DISORDERS, 2020, 35 : S482 - S483
  • [8] In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease
    Kordower, JH
    ANNALS OF NEUROLOGY, 2003, 53 : S120 - S132
  • [9] Mutation analysis of the glial cell line-derived neurotrophic factor gene in Parkinson's disease
    Wartiovaara, K
    Hytönen, M
    Vuori, M
    Paulin, L
    Rinne, J
    Sariola, H
    EXPERIMENTAL NEUROLOGY, 1998, 152 (02) : 307 - 309
  • [10] Unraveling the role of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease
    Kakoty, Violina
    Sarathlal, K. C.
    Kaur, Palwinder
    Wadhwa, Pankaj
    Vishwas, Sukriti
    Khan, Farhan R.
    Alhazmi, Abdulfattah Yahya M.
    Almasoudi, Hassan Hussain
    Gupta, Gaurav
    Chellappan, Dinesh Kumar
    Paudel, Keshav Raj
    Kumar, Dileep
    Dua, Kamal
    Singh, Sachin Kumar
    NEUROLOGICAL SCIENCES, 2024, 45 (04) : 1409 - 1418